Quick Update for Elevance Health (ELV) Investors

By Chris Stiles • Friday, January 27 12:02 • Permanent Link

Healthcare sector company Elevance Health posted a -2.0% performance today, while the S&P 500 returned 0.76%.

21 analysts are following Elevance Health and have set target prices ranging from $500 to $620 per share. On average, they have given the company a rating of buy. At today's prices, ELV is trading -15.12% away from its average analyst target price of $579.95 per share.

Over the last year, ELV's share price has increased by 13.6%, which represents a difference of 22.0% when compared to the S&P 500. The stock's 52 week high is $549.52 per share whereas its 52 week low is $431.5. With an average free cash flow of $7,309,333,333.3 that have been growing at an average rate of 34.6% over the last four years, Elevance Health is in a position to continue its strong stock performance trend.

Date Reported	Cash Flow from Operations ($ MM)	Capital expenditures ($ MM)	Free Cash Flow ($ MM)	YoY Growth (%)
2021-12-31	8,364	-1,087	7,277	-24.72
2020-12-31	10,688	-1,021	9,667	93.96
2019-12-31	6,061	-1,077	4,984	n/a

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.